INFECTION PREVENTION
HaloFogger and HaloMist
particular, during the COVID-19 crisis, our system has been an integral part of
routine cleaning in rooms on COVID fl oors of hospitals and for ambulances and other emergency transport vehicles that have been exposed to potentially COVID- positive patients.” David St. Clair, Halosil International
“During the early stages of the pandemic, multiple customers quickly disinfected emergency treatment
(Surge) tents at several locations with minimal staff and quick turnover, and now are using SteraMist to disinfect vaccine spaces. The Pfi zer facility creating the coronavirus Pfi zer-BioNTech vaccine uses a SteraMist Custom Engineered System (CES) to decontaminate their cleanrooms with 20 SteraMist applicators throughout four cleanrooms. Both our surface and environment unit were used successfully for the reprocessing of tens of thousands of N95 masks at various well-known academic healthcare facilities around the United States for data submission to the FDA. “‘The Total SteraMist Disinfection Cart has been very easy to use on every surface and the technology kills a wide variety of pathogens. We use SteraMist disinfection in our ER isolation rooms and for COVID-19 patient rooms,’
-– Kyle Swanger, Director of
Environmental Services, St. Luke’s Medical Center.
‘Since implementing SteraMist, MorseLife’s number of COVID, C.
TOMI’s SteraMist
diff and general fl u cases have been lowered. SteraMist has provided all of the healthcare employees, patients and family members with confi dence and peace of mind with deeply disinfected environments.’ –Stephen Shell, Risk Manager, MorseLife Health System.”
Dr. Halden Shane, TOMI Environmental Solutions
“EVS and IP teams have shifted the way they use Tru-D SmartUVC in order to combat SARS-CoV-2. More attention is being paid to mobile devices or
those that are used on multiple patients, like blood pressure cuffs and stethoscopes. There has also been increased focus on areas that previously were not considered priority targets for no-touch disinfection, such as public bathrooms and staff work areas.” Alice Brewer, Tru-D SmartUVC
Tru-D SmartUVC – a PDI Solution
“Our customers have responded
by increasing PPE, physically distancing and running their Lytbots after every discharge and isolation to ensure pathogen eradication. One client, St. Tammany Health System, takes a reading on pathogen load in a room before and after manual cleaning and again after UV disinfection with the Lytbot; this ensures accuracy in reporting and helps to maintain their very low infection rates. A hospital of their size is expected to have 30 cases of C. diff per year, but due to their robust disinfection protocols, they only see around seven; this amounts to 78% fewer cases than expected for their facility class.” Adam Steinhoff, Co-founder, CEO, Solaris Robots
nora fl ooring from Interface Julie Stegeman, Interface
Solaris Robots’ Lytbot 1.0
“The past year has shown us the true value of EVS teams and uncovered some of the ineffi ciencies in environmental disinfection within healthcare facilities. In addition to utilizing standard cleaning
38 July 2021 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
“To drive environmental hygiene best practices, our frontline partners are increasingly relying on digital resources. One way UVDI supports this is with the advanced SmartData portal built into the UVDI-360 Room Sanitizer; it can store key details for any room disinfection protocol, including room location, device operator and disinfection cycle length. The UVDI-360 is a lightweight device easily maneuvered to potentially high-risk areas across a facility – where it provides rapid UV-C room disinfection in fi ve to 10 minutes. Our Environmental Services partners are increasingly standardizing enhanced environmental hygiene – not only in patient rooms for terminal cleaning, but also in operating rooms, isolation rooms, ICUs, Labor and Delivery, the Emergency Department, Hematology/Oncology and many more sites.”
Kristine Steely, UVDI UVDI-360
and disinfecting methods and products, such as our Clorox Healthcare portfolio of manual disinfectants, technological advancements, like electrostatic technology, can help in keeping both patient and public spaces safe and healthy. At CloroxPro, we offer a portfolio of electrostatic devices paired with EPA-approved chemistries. Electrostatic devices are engineered to disinfect areas more quickly and effi ciently throughout a healthcare facility.” Doe Kley, Clorox Professional Products Co.
“Continuously looking into improving the effi ciency and quality of cleaning and disinfection practices is key to enhancing patient safety both now and as facilities plan for the future. This can be accomplished by investing in innovative products, such as our HYGEN microfi ber, proven to remove 99.7 % or more of tested microorganisms with water alone, including C. diff and MRSA*, coupled with adjunct technologies, such as UVC or dry hydrogen peroxide that support standard cleaning and disinfection.”
*Based on third party testing with water only on VCT surface. Tested Virus: Feline Calicivirus (substitute for Human Norovirus), common human coronavirus OC43. Tested Bateria: Clostridioides diffi cile (C. diff), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa. Not tested on COVID-19.
Andrew Rushworth, Rubbermaid Commercial Products
“Continual knowledge sharing around product and technology innovations and best practices among EVS leadership across health systems is the most effective way to proactively address infection control. Interface offers a full suite of fl ooring options – carpet tile, LVT, nora rubber fl ooring and now vinyl sheet – to meet the specifi c needs and requirements of healthcare facilities.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62
